On the contrary, the OPG, a soluble decoy receptor for RANKL, competitively binds with RANKL, thereby blocking the interaction between RANKL and RANK and benefiting RA treatment (Udagawa et al., 2021). The gene discussed is TNFRSF11A; the disease is rheumatoid arthritis.